Phase I & Clinical Pharmacokinetics - Anti-Cancer Agents


NIH 1995 N01 CM	Phase I Clinical Pharmacokinetic Studies - Antineoplastic Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio
NIH 1994 N01 CM	Phase I Clinical Pharmacokinetic Studies - Antineoplastic Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio
NIH 1994 N01 CM	Phase I Clinical Pharmacokinetic Studies - Antineoplastic Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio
NIH 1993 N01 CM	Phase I and Clinical Pharmacokinetic Studies of Anti- Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio
NIH 1992 N01 CM	Phase I and Clinical Pharmacokinetic Studies of Anti- Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio
NIH 1991 N01 CM	Phase I and Clinical Pharmacokinetic Studies of Anti- Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio
NIH 1990 N01 CM	Phase I & Clinical Pharmacokinetics - Anti-Cancer Agents Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio
NIH 1990 N01 CM	Phase I and Clinical Pharmacokinetic Studies of Anti- Von Hoff, Daniel D. / University of Texas Health Science Center San Antonio

Huhn, R D; Yurkow, E J; Kuhn, J G et al. (1995) Pharmacodynamics of daily subcutaneous recombinant human interleukin-3 in normal volunteers. Clin Pharmacol Ther 57:32-41